Total Payments
$2,670
2024 Payments
$22.36
Companies
22
Transactions
153
Medicare Patients
1,204
Medicare Billing
$95,733
Payment Breakdown by Category
Food & Beverage$2,670 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,670 | 153 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $448.46 | 26 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $407.46 | 23 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $304.33 | 18 | $0 (2020) |
| Amgen Inc. | $277.11 | 15 | $0 (2020) |
| Relypsa, Inc. | $202.67 | 13 | $0 (2019) |
| Lilly USA, LLC | $194.48 | 12 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $152.79 | 8 | $0 (2020) |
| Hikma Pharmaceuticals USA | $117.47 | 7 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $82.60 | 3 | $0 (2023) |
| AKEBIA THERAPEUTICS INC | $82.51 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.36 | 1 | Novo Nordisk Inc ($22.36) |
| 2023 | $128.45 | 6 | Bayer Healthcare Pharmaceuticals Inc. ($82.60) |
| 2022 | $38.01 | 2 | Evoke Pharma, Inc. ($38.01) |
| 2021 | $32.48 | 2 | Allergan, Inc. ($17.23) |
| 2020 | $456.32 | 26 | Merck Sharp & Dohme Corporation ($76.31) |
| 2019 | $897.58 | 53 | Merck Sharp & Dohme Corporation ($193.39) |
| 2018 | $468.75 | 28 | Merck Sharp & Dohme Corporation ($120.06) |
| 2017 | $626.22 | 35 | Novo Nordisk Inc ($192.59) |
All Payment Transactions
153 individual payment records from CMS Open Payments — Page 2 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/01/2020 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/20/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/04/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: RESPIRATORY | ||||||
| 02/26/2020 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/25/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Diabetes | ||||||
| 02/11/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: RESPIRATORY | ||||||
| 02/05/2020 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: Diabetes | ||||||
| 01/29/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/22/2020 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Diabetes | ||||||
| 01/20/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Cardiovascular | ||||||
| 01/08/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: RESPIRATORY | ||||||
| 01/06/2020 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Nephrology | ||||||
| 12/19/2019 | PFIZER INC. | CHANTIX (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/17/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/04/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: Diabetes | ||||||
| 11/25/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: NEPHROLOGY | ||||||
| 11/15/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/04/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: KRYSTEXXA | ||||||
| 10/29/2019 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Nephrology | ||||||
| 10/23/2019 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/02/2019 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Nephrology | ||||||
| 09/25/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/23/2019 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.65 | General |
| Category: NEPHROLOGY | ||||||
| 09/18/2019 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/16/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 6 | 144 | 159 | $11,600 | $4,917 |
| 2021 | 2 | 38 | 39 | $3,165 | $1,127 |
| 2020 | 10 | 1,022 | 1,498 | $229,385 | $89,689 |
Total Patients
1,204
Total Services
1,696
Medicare Billing
$95,733
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 26 | 28 | $3,360 | $1,420 | 42.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 46 | 47 | $3,055 | $1,236 | 40.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 24 | 27 | $2,025 | $1,226 | 60.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 22 | 23 | $2,300 | $811.88 | 35.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 13 | 18 | $540.00 | $172.29 | 31.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 13 | 16 | $320.00 | $51.52 | 16.1% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 18 | 18 | $1,800 | $635.94 | 35.3% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 20 | 21 | $1,365 | $490.79 | 36.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 136 | 368 | $60,720 | $24,722 | 40.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 142 | 244 | $61,000 | $21,587 | 35.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 154 | 154 | $46,200 | $21,114 | 45.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 46 | 53 | $16,960 | $6,889 | 40.6% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 91 | 91 | $11,375 | $5,551 | 48.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 70 | 102 | $17,340 | $4,769 | 27.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 104 | 104 | $6,240 | $2,053 | 32.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 12 | 12 | $4,080 | $1,363 | 33.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 211 | 311 | $3,110 | $926.37 | 29.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 56 | 59 | $2,360 | $714.37 | 30.3% |
About Dr. Lawrence Ross, M.D
Dr. Lawrence Ross, M.D is a Nephrology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962466201.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lawrence Ross, M.D has received a total of $2,670 in payments from pharmaceutical and medical device companies, with $22.36 received in 2024. These payments were reported across 153 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,670).
As a Medicare-enrolled provider, Ross has provided services to 1,204 Medicare beneficiaries, totaling 1,696 services with total Medicare billing of $95,733. Data is available for 3 years (2020–2022), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Bronx, NY
- Active Since 04/13/2006
- Last Updated 06/08/2015
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1962466201
Products in Payments
- JANUVIA (Drug) $407.46
- Parsabiv (Biological) $219.46
- Tresiba (Drug) $218.95
- Veltassa (Drug) $202.67
- TRULICITY (Drug) $194.48
- SYMBICORT (Drug) $137.85
- STIOLTO RESPIMAT (Drug) $133.61
- Mitigare (Drug) $117.47
- LOKELMA (Drug) $103.78
- Ozempic (Drug) $84.32
- Kerendia (Drug) $82.60
- AURYXIA (Drug) $82.51
- Victoza (Drug) $70.81
- Velphoro (Drug) $54.41
- ENTRESTO (Drug) $49.06
- Parsabiv (Drug) $43.38
- Levemir (Drug) $42.94
- JYNARQUE (Drug) $40.54
- FARXIGA (Drug) $39.34
- GIMOTI (Drug) $38.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Bronx
Dr. Bruce Spinowitz, M.d, M.D
Nephrology — Payments: $510,667
Nephrology $510,667
Joel Neugarten, Md, MD
Nephrology — Payments: $384,806
Nephrology $384,806
Enver Akalin, M.d, M.D
Nephrology — Payments: $76,364
Nephrology $76,364
John He, Md, MD
Nephrology — Payments: $24,885
Nephrology $24,885
Abdurhman Ahmed, M.d, M.D
Nephrology — Payments: $12,466
Nephrology $12,466
Dr. Suman Reddy, Md, MD
Nephrology — Payments: $7,783
Nephrology $7,783